Open Philanthropy recommended a grant of $879,136 to Sightsavers to support a trial in Ethiopia testing whether adding ivermectin to standard trachoma mass drug administration efforts can improve disease elimination efforts.
This falls within Open Philanthropy’s focus area of global health R&D.